MONTREAL, CANADA--(Marketwire - Oct 18, 2012) - Paladin Labs Inc. ("Paladin") (PLB.TO), a leading Canadian specialty pharmaceutical company, today announced that it has entered into a licensing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results